![A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80785-1/MediaObjects/41598_2020_80785_Fig1_HTML.png)
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
Colon Cancer-Specific Antigen-2 May Be Used as a Detecting and Prognostic Marker in Colorectal Cancer: A Preliminary Observation | PLOS ONE
![Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram](https://www.researchgate.net/publication/7660990/figure/fig2/AS:203056043040780@1425423741964/Preoperative-s-CEA-levels-and-disease-free-survival-rate-of-stage-III-colorectal-cancer.png)
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
![CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram](https://www.researchgate.net/publication/12028873/figure/tbl1/AS:667705808007184@1536204878843/CEA-levels-and-circulatory-CEA-clearance-rates-in-colorectal-cancer-patients-Patients-2.png)
CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram
![Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59031-1/MediaObjects/41598_2020_59031_Fig1_HTML.png)
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
![Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine](https://www.thelancet.com/cms/asset/4951d238-4770-4f59-b459-8b7b6d389a17/gr1.jpg)
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Colon Cancer-Specific Antigen-2 May Be Used as a Detecting and Prognostic Marker in Colorectal Cancer: A Preliminary Observation | PLOS ONE
![CEA in Activated Macrophages. New Diagnostic Possibilities for Tumor Markers in Early Colorectal Cancer | Anticancer Research CEA in Activated Macrophages. New Diagnostic Possibilities for Tumor Markers in Early Colorectal Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/29/8/3245/F1.large.jpg)
CEA in Activated Macrophages. New Diagnostic Possibilities for Tumor Markers in Early Colorectal Cancer | Anticancer Research
![Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2012.605/MediaObjects/41416_2013_Article_BFbjc2012605_Fig1_HTML.jpg)
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr1.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/4/5/e004385/F6.large.jpg)
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open
![Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. - Abstract - Europe PMC Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4272469/bin/MA-67-397-g007.jpg)